• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CONCORD MANUFACTURING LIBERTY SELECT CYCLER ASSY(NON-VALUATED); SYSTEM, PERITONEAL, AUTOMATIC DELIVERY Back to Search Results
Catalog Number RTLR180343
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Hypervolemia (2664); Pericarditis (4448)
Event Date 07/17/2023
Event Type  Injury  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.Clinical investigation: there is no indication of a serious injury, patient death, or other adverse event related to a fresenius product or other issue.
 
Event Description
It was reported that this male peritoneal dialysis (pd) patient had been hospitalized on (b)(6) 2023 due to inadequate dialysis at home.During an attempted follow-up call to the clinic, the dietician stated the patient was transitioning to in-center hemodialysis (hd).Additional follow-up with the clinic manager documented that the patient was admitted to the hospital on (b)(6) 2023 with a diagnosis of uremic pericarditis.The patient had signs of fluid retention upon hospital admission.During the hospitalization, the patient underwent a pericardiocentesis to remove the fluid from the pericardium.Prior to the hospitalization, the patient had encountered complications with pd therapy.The patient had no residual renal function and initially an adequacy test showed pd therapy was not sufficient.The patient¿s pd prescription had been changed to attempt to correct this.It was eventually discovered that the patient had a pleuroperitoneal leak.Due to this finding and the fluid buildup around the pericardium, it was decided that the patient required transition to hd.A central venous catheter (cvc) was placed, and the patient¿s pd catheter was pulled.The patient was discharged on (b)(6) 2023 and was initiated on in-center hd.The patient¿s hospitalization and fluid retention are unrelated to the liberty select cycler or any fresenius product(s).The patient¿s pleuroperitoneal leak, an anatomic defect of the patient, is the cause of the uremic pericarditis, hospitalization, and transition to hd.The cause of pd fluid leaks is considered to be mainly due to congenital or acquired diaphragmatic defects in the patient.There are multiple predisposing mechanisms for pleuroperitoneal leaks including diaphragmatic muscular hypotonia, congenital diaphragmatic defects, pleuroperitoneal pressure gradients, and lymphatic drainage disorders.In cases of pleuroperitoneal leak, it is the physiology of the patient and not the device that is the cause of the adverse event.There is no indication of a serious injury, patient death, or other adverse event related to a fresenius product or other issue.
 
Manufacturer Narrative
Plant investigation: no parts were returned to the manufacturer for physical evaluation.A records review was performed on the reported serial number.An investigation of the device manufacturing records was conducted by the manufacturer.There were no non-conformances, or any associated rework identified during the manufacturing process which could be related to the reported event.In addition, the device history record (dhr) review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The investigation into the cause of the reported problem was not able to be confirmed.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.Clinical investigation: there is no indication of a serious injury, patient death, or other adverse event related to a fresenius product or other issue.
 
Event Description
It was reported that this male peritoneal dialysis (pd) patient had been hospitalized on (b)(6) 2023 due to inadequate dialysis at home.During an attempted follow-up call to the clinic, the dietician stated the patient was transitioning to in-center hemodialysis (hd).Additional follow-up with the clinic manager documented that the patient was admitted to the hospital on (b)(6) 2023 with a diagnosis of uremic pericarditis.The patient had signs of fluid retention upon hospital admission.During the hospitalization, the patient underwent a pericardiocentesis to remove the fluid from the pericardium.Prior to the hospitalization, the patient had encountered complications with pd therapy.The patient had no residual renal function and initially an adequacy test showed pd therapy was not sufficient.The patient¿s pd prescription had been changed to attempt to correct this.It was eventually discovered that the patient had a pleuroperitoneal leak.Due to this finding and the fluid buildup around the pericardium, it was decided that the patient required transition to hd.A central venous catheter (cvc) was placed, and the patient¿s pd catheter was pulled.The patient was discharged on (b)(6) 2023 and was initiated on in-center hd.The patient¿s hospitalization and fluid retention are unrelated to the liberty select cycler or any fresenius product(s).The patient¿s pleuroperitoneal leak, an anatomic defect of the patient, is the cause of the uremic pericarditis, hospitalization, and transition to hd.The cause of pd fluid leaks is considered to be mainly due to congenital or acquired diaphragmatic defects in the patient.There are multiple predisposing mechanisms for pleuroperitoneal leaks including diaphragmatic muscular hypotonia, congenital diaphragmatic defects, pleuroperitoneal pressure gradients, and lymphatic drainage disorders.In cases of pleuroperitoneal leak, it is the physiology of the patient and not the device that is the cause of the adverse event.There is no indication of a serious injury, patient death, or other adverse event related to a fresenius product or other issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIBERTY SELECT CYCLER ASSY(NON-VALUATED)
Type of Device
SYSTEM, PERITONEAL, AUTOMATIC DELIVERY
Manufacturer (Section D)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer (Section G)
CONCORD MANUFACTURING
director, quality systems
4040 nelson avenue
concord CA 94520
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key17499138
MDR Text Key320792398
Report Number0002937457-2023-01174
Device Sequence Number1
Product Code FKX
UDI-Device Identifier00840861102068
UDI-Public00840861102068
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181108
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 09/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue NumberRTLR180343
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Date Manufacturer Received08/31/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
DELFLEX PD FLUID; DELFLEX PD FLUID; LIBERTY CYCLER SET; LIBERTY CYCLER SET
Patient Outcome(s) Hospitalization;
Patient Age19 YR
Patient SexMale
-
-